SEATTLE, Dec. 21, 2009 -- The home page of today's Seattlepi.com features an article about the Life Sciences Discovery Fund-supported SLEUTH Trial that Swedish Neuroscience Institute (SNI) co-director and neurosurgeon David Newell, M.D., took part in as the principal investigator.
SNI took part in this phase I clinical trial in conjunction with Bothell, WA-based Ekos Corporation.
To read this article on Seattlepi.com, click here.
###
